A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
about
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipientsTarget of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipientsSirolimus is associated with new-onset diabetes in kidney transplant recipients.Randomized trial of immunosuppressive regimens in renal transplantation.Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.Current and future immunosuppressive strategies in renal transplantation.Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysisA prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Effect of FTY720 (fingolimod) on graft survival in renal transplant recipients: a systematic review protocol.Daclizumab.Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.Composite tissue allotransplantation of the face: Decision analysis model.An evaluation of sirolimus in renal transplantation.Growing experience with mTOR inhibitors in pediatric solid organ transplantation.Practical considerations for the use of mTOR inhibitors.Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosisSingle-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.Enteric-coated mycophenolate sodium.Mycophenolate mofetil: long-term outcomes in solid organ transplantation.Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients.Induction sirolimus and delayed graft function after deceased donor kidney transplantation in the United States.Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosing.Outcome of renal transplants from pediatric donors <5 yr of age.Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure.Machine perfusion following static cold storage preservation in kidney transplantation: donor-matched pair analysis of the prognostic impact of longer pump time.Predisposing factors of diminished survival in simultaneous liver/kidney transplantation.Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation.Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients.Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren.Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study.Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation.Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine
P2860
Q24245456-737C0028-26DE-4C02-A52A-5306B84755F4Q24246340-DA3558E1-6FD5-4551-865D-F3A0AC014F89Q34767143-4B6659B4-CEE7-4233-B19D-C0516386C1F7Q35210227-8EAFB05F-3F46-4223-B7C9-C9080C1AFE37Q35845541-E309D415-A985-40C5-94ED-205131697654Q35906315-E95A3DD9-4F95-495F-B384-831270377C84Q35977704-45F61707-8C32-4A3F-95E4-9CE1C37132ABQ36183858-7A16F097-1FE0-4056-96B4-366E624A8D9CQ36777485-E5C4246D-06D9-41D3-80C9-1B0E3029A5C3Q36861092-027EF016-5A51-41BC-8B0B-A1438E68DD5EQ36960518-E04417BE-06C2-40DC-944D-DF875ADED11DQ37157896-ED81ECF5-BBF8-4B0F-ABF0-22917725DE3FQ37204903-B9FE8002-7489-4D67-AC5B-50DC281477B0Q38038696-5492AD6C-F120-4D99-BC1A-C1F95E948142Q38134146-2445F978-4DB3-46B5-AEA3-22E0D5425FEAQ38863078-B8A8FBCD-2545-4068-9005-77364C3E01F2Q38909490-43B9653D-B4E2-4B1B-87F7-FCD8999AE835Q41681683-586B98DA-A241-48AE-8791-280454F046F3Q42925114-1C436EF6-077E-4CE8-9DFE-1DAA3EE955B0Q43061583-DFB46A02-5844-4763-A12E-72465BF834AEQ43485988-4BEE2054-26D2-4880-95C9-5239A2403A0AQ44981183-8B7F4F26-8B43-4FD4-8D18-87CE12E645E2Q44989320-ECF61A9A-229C-4E4D-BFC5-ABCBAE82B1CAQ46475771-DDB138F2-1BB9-40E3-882B-A0F16005213FQ46582082-78D86A7A-1F57-4858-8475-8DCC930EF19FQ47350874-666959FA-E3D0-4AF0-9B95-2BC5386016AFQ51333234-720321FD-25B5-46F3-921B-74455D2451A1Q52888129-646795C8-85C9-4FD7-8FC0-3FB7D4833E4EQ53325028-35E3F4F7-8AD8-423B-AF55-243AD13A10DDQ53639918-E0769587-8A92-41EE-973D-0A27B1BD868BQ54324332-ED0D7998-CB59-4327-98DA-FC997CD938BEQ54334382-0AD3583E-C155-4B9F-8B43-3C95BDD031E9Q54335179-B1F000EE-C106-4AFD-86EA-1D9D481BD8A2Q57793005-49CCBA90-3926-4CE2-8234-FF296E7D05C1
P2860
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A randomized long-term trial o ...... ons and rejection at one year.
@en
type
label
A randomized long-term trial o ...... ons and rejection at one year.
@en
prefLabel
A randomized long-term trial o ...... ons and rejection at one year.
@en
P2093
P1433
P1476
A randomized long-term trial o ...... ons and rejection at one year.
@en
P2093
Adela Mattiazzi
Anne Rosen
David Roth
Gaetano Ciancio
George W Burke
Jeffrey J Gaynor
Joshua Miller
Maud Nicolas
Phillip Ruiz
Warren Kupin
P304
P356
10.1097/01.TP.0000101290.20629.DC
P577
2004-01-01T00:00:00Z